Table 2.
Characteristics and classification of ADRs
| Variables | General [mean(±SD)] |
|---|---|
| Age (years) | 7.2 (±5.9) |
| Number | 19 |
| Concomitant medications | 3.7(±2.7)* |
| Hospital stay (days) | 14 (+17)+ |
| Naranjo [average points] | 6.2 (±2) |
| 1–4 points (Possible) | 2 |
| 5–8 points (Probable) | 13 |
| ≥ 9 points (Certain) | 4 |
| Schumock & Thornton Scale | |
| Preventable | 4/19 (21%) |
| Not preventable | 15/19 (79%) |
| Hartwig & Siegel [average level] | 2.3 (±1.0) |
| Level 1 | 4 |
| Level 2 | 8 |
| Level 3 | 5 |
| Level 4 | 1 |
| Level 5 | 1 |
Classification of ADRs ADRs were classified according to the Naranjo, Schumock & Thornton and Hartwig & Siegel scale
*The comparison between ADR group and without-ADR was significant (P < 0.05; Chi-square)
+The comparison of hospital stay between ADR group and without-ADR was significant (P < 0.05; U Mann-Whitney)
ADRs Adverse Drug Reactions